Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8750
Corporate User License Price USD 375
Corporate User License Price INR 26250
Site License Price USD 250
Site License Price INR 17500
Request a Quote

Report Title

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review



Executive Summary

Dynavax Technologies Corp (DVAX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dynavax Technologies Corp (Dynavax), formerly Double Helix Corp, is a clinical-stage biopharmaceutical company that develops product candidates for the prevention of infectious and inflammatory disease. The company's only marketed product Heplisav-B is an adult vaccine for hepatitis B. Its pipeline includes AZD1419, a drug for the treatment of asthma; DV281, an agonist which focuses on lung tumors and lung metastases; and SD-101, an agonist focusing on immune response to various cancers. Dynavax's pre-clinical pipeline encompasses DV230F for liver tumors, DV1001 for multiple malignancies. The company develops immunotherapies based on toll-like receptor technology for the treatment and prevention of infectious and inflammatory diseases and cancer. It has subsidiary in Germany. Dynavax is headquartered in Berkeley, California, the US.

Dynavax Technologies Corp Key Recent Developments

Aug 06,2018: Dynavax reports second quarter 2018 financial results

Jun 28,2018: Dynavax Appoints Scientific Advisory Board to Support its Oncology and Vaccine Programs

May 08,2018: Dynavax Announces First Quarter 2018 Financial Results

Mar 08,2018: Dynavax Reports Fourth Quarter and Year End 2017 Financial Results

Mar 02,2018: Stanley A. Plotkin, M.D. Steps Down from Board of Dynavax Technologies

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Dynavax Technologies Corp-Key Facts 5

Dynavax Technologies Corp-Key Employees 6

Dynavax Technologies Corp-Major Products and Services 7

Dynavax Technologies Corp-History 8

Dynavax Technologies Corp-Company Statement 9

Dynavax Technologies Corp-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

Dynavax Technologies Corp-Business Description 14

R&D Overview 14

Dynavax Technologies Corp-SWOT Analysis 15

SWOT Analysis-Overview 15

Dynavax Technologies Corp-Strengths 15

Dynavax Technologies Corp-Weaknesses 16

Dynavax Technologies Corp-Opportunities 17

Dynavax Technologies Corp-Threats 18

Dynavax Technologies Corp-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Dynavax Technologies Corp, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Aug 06, 2018: Dynavax reports second quarter 2018 financial results 29

Jun 28, 2018: Dynavax Appoints Scientific Advisory Board to Support its Oncology and Vaccine Programs 31

Mar 08, 2018: Dynavax Reports Fourth Quarter and Year End 2017 Financial Results 33

Mar 02, 2018: Stanley A. Plotkin, M.D. Steps Down from Board of Dynavax Technologies 34

Nov 03, 2017: Dynavax Reports Third Quarter 2017 Financial Results 35

Aug 02, 2017: Dynavax Reports Second Quarter 2017 Financial Results 36

Jun 21, 2017: Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance 37

May 08, 2017: Dynavax Reports First Quarter 2017 Financial Results 38

Mar 13, 2017: Dynavax Reports Fourth Quarter and Year End 2016 Financial Results and Company Update 39

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Dynavax Technologies Corp, Performance Chart (2013-2017) 23

Dynavax Technologies Corp, Ratio Charts 25

Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

List of Tables

Dynavax Technologies Corp, Key Facts 5

Dynavax Technologies Corp, Key Employees 6

Dynavax Technologies Corp, Major Products and Services 7

Dynavax Technologies Corp, History 8

Dynavax Technologies Corp, Subsidiaries 12

Dynavax Technologies Corp, Key Competitors 19

Dynavax Technologies Corp, Ratios based on current share price 20

Dynavax Technologies Corp, Annual Ratios 21

Dynavax Technologies Corp, Annual Ratios (Cont...1) 22

Dynavax Technologies Corp, Interim Ratios 24

Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Dynavax Technologies Corp, Recent Deals Summary 28

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Immunomedics Inc

Idera Pharmaceuticals Inc

Globeimmune Inc

Dynavax Technologies Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person